Many studies revealed that MIAT has been demonstrated as a key switcher in regulation of various biological and pathological processes in human cancers including non-small-cell lung cancer, neuroendocrine prostate cancer, and colorectal cancer [20–22]. This evidence concerns the gene MIAT and colorectal cancer.